메뉴 건너뛰기




Volumn 124, Issue 3, 2014, Pages 1341-1349

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

Author keywords

[No Author keywords available]

Indexed keywords

BENZONITRILE C 11; BUSPIRONE; DOPAMINE; LEVODOPA; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; ANTIPARKINSON AGENT; DIAGNOSTIC AGENT; RACLOPRIDE; SEROTONIN 1 AGONIST;

EID: 84896751626     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71640     Document Type: Article
Times cited : (199)

References (39)
  • 1
    • 0017717778 scopus 로고
    • "Off period" dystonia and "on period" choreoathetosis in levodopatreated patients with Parkinson's disease
    • Lees AJ, Shaw KM, Stern GM. "Off period" dystonia and "on period" choreoathetosis in levodopatreated patients with Parkinson's disease. Lancet. 1977;2(8046):1034.
    • (1977) Lancet , vol.2 , Issue.8046 , pp. 1034
    • Lees, A.J.1    Shaw, K.M.2    Stern, G.M.3
  • 2
    • 10344236071 scopus 로고    scopus 로고
    • Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
    • de la Fuente-Fernández R, et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain. 2004;127(12):2747-2754.
    • (2004) Brain , vol.127 , Issue.12 , pp. 2747-2754
    • De La Fuente-Fernández, R.1
  • 3
    • 0014930392 scopus 로고
    • L-Dopainduced release of cerebral monoamines
    • Ng KY, Chase TN, Colburn RW, Kopin IJ. L-Dopainduced release of cerebral monoamines. Science. 1970;170(3953):76-77.
    • (1970) Science , vol.170 , Issue.3953 , pp. 76-77
    • Ng, K.Y.1    Chase, T.N.2    Colburn, R.W.3    Kopin, I.J.4
  • 4
    • 0015207733 scopus 로고
    • Effects of L-dopa on efflux of cerebral monoamines from synaptosomes
    • Ng KY, Colburn RW, Kopin IJ. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes. Nature. 1971;230(5292):331-332.
    • (1971) Nature , vol.230 , Issue.5292 , pp. 331-332
    • Ng, K.Y.1    Colburn, R.W.2    Kopin, I.J.3
  • 5
    • 0033601926 scopus 로고    scopus 로고
    • Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats
    • Tanaka H, Kannari K, Maeda T, Tomiyama M, Suda T, Matsunaga M. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. Neuroreport. 1999;10(3):631-634.
    • (1999) Neuroreport , vol.10 , Issue.3 , pp. 631-634
    • Tanaka, H.1    Kannari, K.2    Maeda, T.3    Tomiyama, M.4    Suda, T.5    Matsunaga, M.6
  • 6
    • 37549029102 scopus 로고    scopus 로고
    • Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
    • Kish SJ, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain. 2008;131(1):120-131.
    • (2008) Brain , vol.131 , Issue.1 , pp. 120-131
    • Kish, S.J.1
  • 7
    • 77955844658 scopus 로고    scopus 로고
    • Staging of serotonergic dysfunction in Parkinson's disease: An in vivo 11C-DASB PET study
    • Politis M, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis. 2010;40(1):216-221.
    • (2010) Neurobiol Dis , vol.40 , Issue.1 , pp. 216-221
    • Politis, M.1
  • 8
    • 0022253616 scopus 로고
    • In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat
    • Schmidt CJ, Lovenberg W. In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat. Neurosci Lett. 1985;59(1):9-14.
    • (1985) Neurosci Lett , vol.59 , Issue.1 , pp. 9-14
    • Schmidt, C.J.1    Lovenberg, W.2
  • 9
    • 0346422386 scopus 로고    scopus 로고
    • Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake
    • Saldaña SN, Barker EL. Temperature and 3,4- methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake. Neurosci Lett. 2004;354(3):209-212.
    • (2004) Neurosci Lett , vol.354 , Issue.3 , pp. 209-212
    • Saldaña, S.N.1    Barker, E.L.2
  • 10
    • 20144378889 scopus 로고    scopus 로고
    • Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA
    • Maeda T, Nagata K, Yoshida Y, Kannari K. Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA. Brain Res. 2005;1046(1-2):230-233.
    • (2005) Brain Res , vol.1046 , Issue.1-2 , pp. 230-233
    • Maeda, T.1    Nagata, K.2    Yoshida, Y.3    Kannari, K.4
  • 11
    • 33646822115 scopus 로고    scopus 로고
    • Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters
    • Kannari K, Shen H, Arai A, Tomiyama M, Baba M. Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters. Neurosci Lett. 2006;402(1-2):62-65.
    • (2006) Neurosci Lett , vol.402 , Issue.1-2 , pp. 62-65
    • Kannari, K.1    Shen, H.2    Arai, A.3    Tomiyama, M.4    Baba, M.5
  • 12
    • 34447627504 scopus 로고    scopus 로고
    • Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
    • Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 2007;130(7):1819-1833.
    • (2007) Brain , vol.130 , Issue.7 , pp. 1819-1833
    • Carta, M.1    Carlsson, T.2    Kirik, D.3    Björklund, A.4
  • 13
    • 34547115255 scopus 로고    scopus 로고
    • The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy
    • Eskow KL, Gupta V, Alam S, Park JY, Bishop C. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Pharmacol Biochem Behav. 2007;87(3):306-314.
    • (2007) Pharmacol Biochem Behav , vol.87 , Issue.3 , pp. 306-314
    • Eskow, K.L.1    Gupta, V.2    Alam, S.3    Park, J.Y.4    Bishop, C.5
  • 14
    • 33947302427 scopus 로고    scopus 로고
    • Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
    • Dekundy A, Lundblad M, Danysz W, Cenci MA. Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model. Behav Brain Res. 2007;179(1):76-89.
    • (2007) Behav Brain Res , vol.179 , Issue.1 , pp. 76-89
    • Dekundy, A.1    Lundblad, M.2    Danysz, W.3    Cenci, M.A.4
  • 15
    • 58149107401 scopus 로고    scopus 로고
    • Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPAinduced dyskinesia
    • Muñoz A, et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPAinduced dyskinesia. Brain. 2008;131(12):3380-3394.
    • (2008) Brain , vol.131 , Issue.12 , pp. 3380-3394
    • Muñoz, A.1
  • 16
    • 56249141071 scopus 로고    scopus 로고
    • Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat
    • Dupre KB, Eskow KL, Barnum CJ, Bishop C. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology. 2008;55(8):1321-1328.
    • (2008) Neuropharmacology , vol.55 , Issue.8 , pp. 1321-1328
    • Dupre, K.B.1    Eskow, K.L.2    Barnum, C.J.3    Bishop, C.4
  • 17
    • 77349086589 scopus 로고    scopus 로고
    • L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: Temporal and quantitative relationship to the expression of dyskinesia
    • Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. J Neurochem. 2010;112(6):1465-1476.
    • (2010) J Neurochem , vol.112 , Issue.6 , pp. 1465-1476
    • Lindgren, H.S.1    Andersson, D.R.2    Lagerkvist, S.3    Nissbrandt, H.4    Cenci, M.A.5
  • 18
    • 84857195565 scopus 로고    scopus 로고
    • Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning
    • Nahimi A, et al. Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning. J Neurochem. 2012;120(5):806-817.
    • (2012) J Neurochem , vol.120 , Issue.5 , pp. 806-817
    • Nahimi, A.1
  • 19
    • 84881556666 scopus 로고    scopus 로고
    • Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
    • Bezard E, et al. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord. 2013;28(8):1088-1096.
    • (2013) Mov Disord , vol.28 , Issue.8 , pp. 1088-1096
    • Bezard, E.1
  • 20
    • 0036895554 scopus 로고    scopus 로고
    • Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study
    • Khan NL, et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002;52(6):849-853.
    • (2002) Ann Neurol , vol.52 , Issue.6 , pp. 849-853
    • Khan, N.L.1
  • 21
    • 0033955756 scopus 로고    scopus 로고
    • Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
    • de la Fuente-Fernández R, et al. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. J Neural Transm. 2000;107(1):49-57.
    • (2000) J Neural Transm , vol.107 , Issue.1 , pp. 49-57
    • De La Fuente-Fernández, R.1
  • 22
    • 78249271694 scopus 로고    scopus 로고
    • Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
    • Rylander D, et al. Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol. 2010;68(5):619-628.
    • (2010) Ann Neurol , vol.68 , Issue.5 , pp. 619-628
    • Rylander, D.1
  • 23
    • 0035960558 scopus 로고    scopus 로고
    • Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models
    • Bibbiani F, Oh JD, Chase TN. Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology. 2001;57(10):1829-1834.
    • (2001) Neurology , vol.57 , Issue.10 , pp. 1829-1834
    • Bibbiani, F.1    Oh, J.D.2    Chase, T.N.3
  • 24
    • 26444586231 scopus 로고    scopus 로고
    • Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease
    • Bara-Jimenez W, et al. Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. Mov Disord. 2005;20(8):932-936.
    • (2005) Mov Disord , vol.20 , Issue.8 , pp. 932-936
    • Bara-Jimenez, W.1
  • 25
    • 33847757879 scopus 로고    scopus 로고
    • Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial
    • Goetz CG, et al. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007;22(2):179-186.
    • (2007) Mov Disord , vol.22 , Issue.2 , pp. 179-186
    • Goetz, C.G.1
  • 26
    • 46149088212 scopus 로고    scopus 로고
    • Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat
    • Dupre KB, et al. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat. Psychopharmacology. 2008;199(1):99-108.
    • (2008) Psychopharmacology , vol.199 , Issue.1 , pp. 99-108
    • Dupre, K.B.1
  • 27
    • 77955617871 scopus 로고    scopus 로고
    • Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants
    • Politis M, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med. 2010;2(38):38ra46.
    • (2010) Sci Transl Med , vol.2 , Issue.38
    • Politis, M.1
  • 28
    • 80052971467 scopus 로고    scopus 로고
    • Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
    • Politis M, et al. Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord. 2011;26(11):1997- 2003.
    • (2011) Mov Disord , vol.26 , Issue.11 , pp. 1997-2003
    • Politis, M.1
  • 29
    • 78649534741 scopus 로고    scopus 로고
    • Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?
    • Politis M. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? BMC Med. 2010;8:80.
    • (2010) BMC Med , vol.8 , pp. 80
    • Politis, M.1
  • 32
    • 0023897645 scopus 로고
    • Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients
    • Rainero I, et al. Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients. Ital J Neurol Sci. 1988;9(3):225-259.
    • (1988) Ital J Neurol Sci , vol.9 , Issue.3 , pp. 225-259
    • Rainero, I.1
  • 33
    • 0031933827 scopus 로고    scopus 로고
    • Concentrations and effects of buspirone are considerably reduced by rifampicin
    • Lamberg TS, Kivistö KT, Neuvonen PJ. Concentrations and effects of buspirone are considerably reduced by rifampicin. Br J Clin Pharmacol. 1998; 45(4):381-385.
    • (1998) Br J Clin Pharmacol , vol.45 , Issue.4 , pp. 381-385
    • Lamberg, T.S.1    Kivistö, K.T.2    Neuvonen, P.J.3
  • 34
    • 55749087155 scopus 로고    scopus 로고
    • Hypothalamic involvement in Huntington's disease: An in vivo PET study
    • Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain. 2008; 131(11):2860-2869.
    • (2008) Brain , vol.131 , Issue.11 , pp. 2860-2869
    • Politis, M.1    Pavese, N.2    Tai, Y.F.3    Tabrizi, S.J.4    Barker, R.A.5    Piccini, P.6
  • 35
    • 0031279782 scopus 로고    scopus 로고
    • Parametric imaging of ligand-receptor binding in PET using a simplified reference region model
    • Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6(4):279-287.
    • (1997) Neuroimage , vol.6 , Issue.4 , pp. 279-287
    • Gunn, R.N.1    Lammertsma, A.A.2    Hume, S.P.3    Cunningham, V.J.4
  • 36
    • 13844317450 scopus 로고    scopus 로고
    • Regional distribution of serotonin transporter protein in postmortem human brain: Is the cerebellum a SERT-free brain region?
    • Kish SJ, et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nucl Med Biol. 2005;32(2):123-128.
    • (2005) Nucl Med Biol , vol.32 , Issue.2 , pp. 123-128
    • Kish, S.J.1
  • 38
    • 0035200087 scopus 로고    scopus 로고
    • Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: Modeling strategies
    • Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab. 2001;21(11):1342- 1353.
    • (2001) J Cereb Blood Flow Metab , vol.21 , Issue.11 , pp. 1342-1353
    • Ginovart, N.1    Wilson, A.A.2    Meyer, J.H.3    Hussey, D.4    Houle, S.5
  • 39
    • 0034857407 scopus 로고    scopus 로고
    • Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data
    • Turkheimer FE, Smith CB, Schmidt K. Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data. Neuroimage. 2001;13(5):920-930.
    • (2001) Neuroimage , vol.13 , Issue.5 , pp. 920-930
    • Turkheimer, F.E.1    Smith, C.B.2    Schmidt, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.